LSE:SAR (Sareum Plc)
About SAR
Sareum Holdings Plc engages in the discovery and development of drug candidates for the treatment of cancers and autoimmune diseases. Its drug discovery pipeline includes Chk1, TYK2, and Aurora+FLT3 kinases. The company was founded by Timothy John Mitchell, David Hugh Williams, and John Charles Reader on August 1, 2003 and is headquartered in Cambridge, the United Kingdom.
Sareum Plc (LSE: SAR) Latest News
Investing Articles
Should I get invested in this FTSE pharma share?
Investing Articles
The Sareum share price is down 40% in a month. What’s going on?
Investing Articles
Is the falling Sareum Holdings share price an exciting opportunity?
Investing Articles
The Sareum Holdings share price is down 47%! Is now the time to buy?
Investing Articles
What’s going on with the Sareum share price?
Investing Articles
Sareum shares just jumped 22%! Here’s why
Investing Articles
3 penny stocks I’d aim to hold for 10 years
Investing Articles
The Sareum (SAR) share price is surging! Time to buy this penny stock?
Investing Articles
Can the Sareum share price keep surging?
Investing Articles
3 penny stocks I’d buy in my Stocks and Shares ISA right now
Investing Articles
The Sareum share price is exploding higher! Should I jump in?
Investing Articles
Here’s why UK shares Sareum and Biome Technologies are soaring and sinking today!
1❯